China NMPA Product Recall - Hip joint surgical instruments

On August 18, 2020, the National Medical Products Administration (NMPA) announced a voluntary Class II recall initiated by Smith & Nephew Orthopaedics AG. This recall specifically targets certain hip surgery instruments (Registration Certificate Code: "国械备20161805"), which were reported by Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd. The main issue prompting this action is a product design flaw. A critical manufacturing defect has led to an excessively small gap at the connection point where the instruments interface with accompanying surgical tools. This inadequacy creates a significant risk of guide plate breakage during surgical procedures, which could potentially impact patient safety and the success of operations. Under the NMPA's regulatory framework, Smith & Nephew Orthopaedics AG is undertaking this recall to address the product deficiency. The Class II recall designation indicates that the use of the affected product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. The company is mandated to provide detailed information on all affected product models, specifications, and batches, as referenced in the "Medical Device Recall List," to ensure complete removal of these instruments from circulation and clinical use.